Article Details

New data for Roche's OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease ...

Retrieved on: 2021-04-16 05:04:50

Tags for this article:

Click the tags to see associated articles and topics

New data for Roche's OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease .... View article details on hiswai:

Excerpt

Controlling progression can enable people with MS to maintain mobility and limit their disability,” said Levi Garraway, M.D., Ph.D. Roche's Chief Medical ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up